Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA deputy commissioner of operations

This article was originally published in The Tan Sheet

Executive Summary

FDA deputy commissioner of operations: Michael Friedman, MD, associate director of the Cancer Therapy Evaluation Program at the National Cancer Institute in Bethesda, will assume the position of FDA deputy commissioner of operations on October 1. The job was left vacant when Linda Suydam, who held the office on an interim basis, departed Sept. 1 to become associate VP for planning and development at the University of New Mexico in Albuquerque ("The Tan Sheet" Sept. 4, In Brief)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084293

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel